Showing results (1101-1110 of 1,234) with videos related to

Sort By:
Pageof 124
Kidney International|June 19, 2014
The urea decomposition product cyanate promotes endothelial dysfunctionDalia El-Gamal, Shailaja P Rao, Michael Holzer, et al.
Journal of Biomedicine & Biotechnology|June 28, 2008
Differential effects of leptin on the invasive potential of androgen-dependent and -independent prostate carcinoma cellsDayanand D Deo, Ashwin P Rao, Saideep S Bose, et al.
Anticancer Research|January 2, 2010
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell deathShanmugasundaram Ganapathy-Kanniappan, Jean-Francois H Geschwind, Rani Kunjithapatham, et al.
Carcinogenesis|August 29, 2007
Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinomaTheofilos Poutahidis, Kevin M Haigis, Varada P Rao, et al.
Transplantation|January 2, 2007
Increased immunosuppression, not anticoagulation, extends cardiac xenograft survivalGuerard W Byrne, William R Davies, Keiji Oi, et al.
International Journal of Cancer|October 2, 2009
Unifying roles for regulatory T cells and inflammation in cancerSusan E Erdman, Varada P Rao, Werner Olipitz, et al.
Intervirology|December 30, 2020
VP2 Gene-Based Molecular Evolutionary Patterns of Major Circulating Bluetongue Virus Serotypes Isolated during 2014-2018 from Telangana and Andhra Pradesh States of IndiaRavali Thota, Vishweshwar Kumar Ganji, Sharanya Machanagari, et al.
The American Journal of Medicine|November 11, 2017
Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE TrialMeena P Rao, Dragos Vinereanu, Daniel M Wojdyla, et al.
Pharmacotherapy|March 3, 2023
Safety of elexacaftor/tezacaftor/ivacaftor dose reduction: Mechanistic exploration through physiologically based pharmacokinetic modeling and a clinical case seriesEunjin Hong, Regina Li, Alan Shi, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2012
Differential use of CCR5 by HIV-1 clinical isolates resistant to small-molecule CCR5 antagonistsTimothy J Henrich, Nicolas R P Lewine, Sun-Hee Lee, et al.
Pageof 124